Taken together, primary GBM cells in serum-containing medium differentiate, indicated by diminished nestin, increased GFAP intensity, and reduced expression of the putative glioma stem-cell markers, albeit with tumor and culture medium dependent variability. The gene discussed is NES; the disease is glioblastoma.